New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
19:40 EDTINCY, INCY, INCYIncyte to hold an investor briefing
Management holds an Investor Briefing, in conjunction with ASCO, to recap Phase 2 Trial of Ruxolitinib in pancreatic cancer and Phase 1/2 trial of INCB24360 + Ipilimumab in Chicago on June 2 at 7:45 pm. Webcast Link
News For INCY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
17:06 EDTINCYIncyte publish Phase III RESPONSE trial results for polycythemia vera patients
Subscribe for More Information
08:10 EDTINCYIncyte receives orphan status for pancreatic cancer treatment
Subscribe for More Information
January 23, 2015
07:36 EDTINCYIncyte earns $25M milestone payment from Novartis for Jakavi
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use